Iris L. Romero

6.9k total citations · 2 hit papers
38 papers, 4.1k citations indexed

About

Iris L. Romero is a scholar working on Molecular Biology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, Iris L. Romero has authored 38 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Reproductive Medicine. Recurrent topics in Iris L. Romero's work include Metabolism, Diabetes, and Cancer (13 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Ovarian cancer diagnosis and treatment (9 papers). Iris L. Romero is often cited by papers focused on Metabolism, Diabetes, and Cancer (13 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Ovarian cancer diagnosis and treatment (9 papers). Iris L. Romero collaborates with scholars based in United States, Australia and United Kingdom. Iris L. Romero's co-authors include Ernst Lengyel, Kristin M. Nieman, S. Diane Yamada, Marcus E. Peter, Hilary A. Kenny, Bennett Van Houten, Carla Penicka, András Ladányi, Marion Zillhardt and Gökhan S. Hotamışlıgil and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Iris L. Romero

37 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

2011 1.7k citations Kristin M. Nieman, Hilary A. Kenny et al. profile →
Adipose tissue and adipocytes support tumorigenesis and metastasis

2013 595 citations Kristin M. Nieman, Iris L. Romero et al. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids profile →

Peers

Iris L. Romero

ONCOL

IMMUN

Evgeny N. Imyanitov Russia

Susan M. Henshall Australia

Margaret C. Cummings Australia

Barbara Schmalfeldt Germany

Weiyi Fang China

Hiroaki Itamochi Japan

Ricardo R. Lastra United States

Michael J. Seckl United Kingdom

Robert M. Wenham United States

Mohamed Mokhtar Desouki United States

Evgeny N. Imyanitov Russia

Iris L. Romero

2.2k ×0.9

1.2k ×0.7

1.4k ×1.2

ONCOL

299 ×0.6

IMMUN

249 ×0.6

Citations per year, relative to Iris L. Romero Iris L. Romero (= 1×) peers Evgeny N. Imyanitov

Countries citing papers authored by Iris L. Romero

Since Specialization

Citations

This map shows the geographic impact of Iris L. Romero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris L. Romero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris L. Romero more than expected).

Fields of papers citing papers by Iris L. Romero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris L. Romero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris L. Romero. The network helps show where Iris L. Romero may publish in the future.

Co-authorship network of co-authors of Iris L. Romero

This figure shows the co-authorship network connecting the top 25 collaborators of Iris L. Romero. A scholar is included among the top collaborators of Iris L. Romero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris L. Romero. Iris L. Romero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Romero, Iris L., Ernst Lengyel, Andrea E. Wahner Hendrickson, et al.. (2025). Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial. Gynecologic Oncology. 194. 18–24. 3 indexed citations

Romero, Iris L., et al.. (2025). Changes in the Numbers of Male and Female Obstetricians-Gynecologists and Their Implications. Obstetrics and Gynecology Clinics of North America. 52(4). 735–743. 1 indexed citations

Romero, Iris L., et al.. (2023). Investigating Fumarate Hydratase-Deficient Uterine Fibroids: A Case Series. Journal of Clinical Medicine. 12(17). 5436–5436. 3 indexed citations

Bowen, Deborah J., Elizabeth M. Swisher, Karen H. Lu, et al.. (2022). An Accessible Communication System for Population-Based Genetic Testing: Development and Usability Study. JMIR Formative Research. 6(10). e34055–e34055. 2 indexed citations

Romero, Iris L., et al.. (2021). Obstetrics and Gynecology Resident Physician Experiences with Lesbian, Gay, Bisexual, Transgender and Queer Healthcare Training. Medical Science Educator. 31(2). 599–606. 14 indexed citations

Mukherjee, Abir, Kristin M. Nieman, Johannes F. Fahrmann, et al.. (2020). Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance. Cancer Research. 80(8). 1748–1761. 189 indexed citations

Hart, Peter C., Hilary A. Kenny, Niklas Graßl, et al.. (2019). Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk. Cell Reports. 29(12). 4086–4098.e6. 31 indexed citations

Hart, Peter C., Tatsuyuki Chiyoda, Xiaojing Liu, et al.. (2019). SPHK1 Is a Novel Target of Metformin in Ovarian Cancer. Molecular Cancer Research. 17(4). 870–881. 60 indexed citations

Nielsen, Sarah M., Arcangela De Nicolo, Diana Eccles, et al.. (2018). Genetic testing and clinical management practices for variants in non-BRCA1/2 breast (and/or ovarian) cancer susceptibility genes: An international survey by the Enigma Clinical Working Group.. Journal of Clinical Oncology. 36(15_suppl). 1539–1539. 5 indexed citations

10.

Chiyoda, Tatsuyuki, Peter C. Hart, Mark A. Eckert, et al.. (2017). Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention. Cancer Prevention Research. 10(4). 255–266. 26 indexed citations

11.

Liu, Xiaojing, Iris L. Romero, Lacey M. Litchfield, Ernst Lengyel, & Jason W. Locasale. (2016). Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers. Cell Metabolism. 24(5). 728–739. 176 indexed citations

12.

Grushko, Tatyana A., Masha Kocherginsky, Jean Hurteau, et al.. (2016). Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy. PLoS ONE. 11(1). e0147145–e0147145. 42 indexed citations

13.

Lengyel, Ernst, et al.. (2014). Old drug, new trick: Repurposing metformin for gynecologic cancers?. Gynecologic Oncology. 135(3). 614–621. 55 indexed citations

14.

Lengyel, Ernst, Lacey M. Litchfield, Anirban Mitra, et al.. (2014). Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models. American Journal of Obstetrics and Gynecology. 212(4). 479.e1–479.e10. 107 indexed citations

15.

Wroblewski, Kristen, Michael J. Bradaric, S. Diane Yamada, et al.. (2014). Statin Therapy Is Associated with Improved Survival in Patients with Non-Serous-Papillary Epithelial Ovarian Cancer: A Retrospective Cohort Analysis. PLoS ONE. 9(8). e104521–e104521. 39 indexed citations

16.

Nieman, Kristin M., Iris L. Romero, Bennett Van Houten, & Ernst Lengyel. (2013). Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(10). 1533–1541. 595 indexed citations breakdown →

17.

Romero, Iris L., Anirban Mitra, Ilyssa O. Gordon, et al.. (2011). The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis. Gynecologic Oncology. 124(1). 134–141. 11 indexed citations

18.

Chen, Lina, Sun-Mi Park, Alexei V. Tumanov, et al.. (2010). CD95 promotes tumour growth. Nature. 465(7297). 492–496. 300 indexed citations

19.

Romero, Iris L., Ilyssa O. Gordon, Sujatha Jagadeeswaran, et al.. (2009). Effects of Oral Contraceptives or a Gonadotropin-Releasing Hormone Agonist on Ovarian Carcinogenesis in Genetically Engineered Mice. Cancer Prevention Research. 2(9). 792–799. 13 indexed citations

20.

Romero, Iris L., David K. Turok, & Melissa Gilliam. (2007). A randomized trial of tramadol versus ibuprofen as an adjunct to pain control during vacuum aspiration abortion. Contraception. 77(1). 56–59. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact